中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
9期
34-36
,共3页
潘东山%杨恩明%杨水法%王永超%章振保
潘東山%楊恩明%楊水法%王永超%章振保
반동산%양은명%양수법%왕영초%장진보
经尿道前列腺切除术%等离子电切术%前列腺增生
經尿道前列腺切除術%等離子電切術%前列腺增生
경뇨도전렬선절제술%등리자전절술%전렬선증생
Transurethral resection of prostate%Bipolar plasmakinetic resection of prostate%Prostatic hyperplasia
目的 比较经尿道前列腺等离子电切术(PKRP)与经尿道前列腺等离子剜除术(PKEP)治疗良性前列腺增生(BPH)的安全性及临床疗效.方法 回顾性分析2008年1月至2012年3月经PKEP和PKRP治疗的401例良性前列腺增生患者的病例资料,分为PKRP组199例,PKEP组202例.通过比较手术时间、术中出血量、前列腺切除质量和并发症发生率评价两种手术方式的安全性,通过比较术后3个月国际前列腺症状评分(I-PSS)、生活质量评分(QOL)、最大尿流率(Qmax)及残余尿量(RUV)等评价两种手术方式的疗效.结果 PKEP组手术时间、术中出血量、术后冲洗时间和并发症的发生率明显低于PKRP组,前列腺切除质量高于PKRP组,差异有统计学意义(P<0.05);术后3个月两组中I-PSS、QOL、Qmax、RUV较术前都明显改善,但是两组间差异无统计学意义(P>0.05).结论 PKEP与PKRP治疗BPH的疗效相近,但PKEP平均手术时间短、术中出血量少、并发症发生率低,手术安全性更高,对人体生理功能影响小、疗效确切的新手术方法.
目的 比較經尿道前列腺等離子電切術(PKRP)與經尿道前列腺等離子剜除術(PKEP)治療良性前列腺增生(BPH)的安全性及臨床療效.方法 迴顧性分析2008年1月至2012年3月經PKEP和PKRP治療的401例良性前列腺增生患者的病例資料,分為PKRP組199例,PKEP組202例.通過比較手術時間、術中齣血量、前列腺切除質量和併髮癥髮生率評價兩種手術方式的安全性,通過比較術後3箇月國際前列腺癥狀評分(I-PSS)、生活質量評分(QOL)、最大尿流率(Qmax)及殘餘尿量(RUV)等評價兩種手術方式的療效.結果 PKEP組手術時間、術中齣血量、術後遲洗時間和併髮癥的髮生率明顯低于PKRP組,前列腺切除質量高于PKRP組,差異有統計學意義(P<0.05);術後3箇月兩組中I-PSS、QOL、Qmax、RUV較術前都明顯改善,但是兩組間差異無統計學意義(P>0.05).結論 PKEP與PKRP治療BPH的療效相近,但PKEP平均手術時間短、術中齣血量少、併髮癥髮生率低,手術安全性更高,對人體生理功能影響小、療效確切的新手術方法.
목적 비교경뇨도전렬선등리자전절술(PKRP)여경뇨도전렬선등리자완제술(PKEP)치료량성전렬선증생(BPH)적안전성급림상료효.방법 회고성분석2008년1월지2012년3월경PKEP화PKRP치료적401례량성전렬선증생환자적병례자료,분위PKRP조199례,PKEP조202례.통과비교수술시간、술중출혈량、전렬선절제질량화병발증발생솔평개량충수술방식적안전성,통과비교술후3개월국제전렬선증상평분(I-PSS)、생활질량평분(QOL)、최대뇨류솔(Qmax)급잔여뇨량(RUV)등평개량충수술방식적료효.결과 PKEP조수술시간、술중출혈량、술후충세시간화병발증적발생솔명현저우PKRP조,전렬선절제질량고우PKRP조,차이유통계학의의(P<0.05);술후3개월량조중I-PSS、QOL、Qmax、RUV교술전도명현개선,단시량조간차이무통계학의의(P>0.05).결론 PKEP여PKRP치료BPH적료효상근,단PKEP평균수술시간단、술중출혈량소、병발증발생솔저,수술안전성경고,대인체생리공능영향소、료효학절적신수술방법.
Objective To compare the clinical efficacy of transurethral plasma kinetic resection of prostate,PKRP and transurethral plasma kinetic enucleation of prostate,PKEP on benign prostatic hyperplasia (BPH).Methods A total of 401 patients with BPH were enrolled from January 2008 to March 2012,and divided into PKRP group (199 cases)and PKEP group (202 cases).Parameters including intraoperative blood loss,resected tissue weight,operating time,postoperative morbidity rate were compared to evaluate the clinical safety of PKRP and PKEP for the treatment of BPH.International prostate symptom scores (I-PSS),quality of life scores(QOL),maximum urinary flow rates(Qmax) and residual urine volume,(RUV) were compared to evaluate the clinical effect at 3 months postoperatively.Results Operating time,intraoperative bloodloss and postoperative morbidity rate were significantly lower in the PKEP group,resected tissue weight was significantly higher in the PKEP group,I-PSS,QOL,Qmax and RUV significantly improved 3 months postoperatively in both groups,but there was no significant difference between them.Conclusions PKEP and PKRP have similar efficacy on BPH.Because of its less operating time,less blood loss,lower postoperative morbidity rate and higher security,PKEP has a good prospect.